Posts

More than 80% relative bioavailability compared with injectable obesity therapy, well above the roughly 30% reported for existing microneedle patches and setting a new global benchmark A potential game changer that addresses both the pain of injections and the low efficiency of oral formulations In the obesity treatment market, delivery technology is expected to be…

Smartee Denti-Technology announces the publication of a case report on the application of the S8-SGTB clear aligner therapy for treating adult Class II malocclusion in the Journal of Aligner Orthodontics (JAO). The report, titled “Treatment of Class II malocclusion with sagittal guidance twin block clear aligners (S8-SGTB): A report of three cases,” presents the process and outcomes of three…

HopeAI, an emerging leader in applying artificial intelligence (AI) to accelerate new drug development, has officially joined the prestigious Mayo Clinic Platform Accelerate program. This partnership grants HopeAI access to Mayo Clinic’s world-class real-world data (RWD) platform, enabling faster, smarter, and more confident clinical trial design. Bringing a new drug to market is one of the most…